Recent studies also suggest that portal fibrogenesis in NASH is associated with, and potentially mediated by, a Th17 response via increased expression of IL-1β, TGFβ, and IL-6. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.